BHC Projected Dividend Yield
Bausch Health Companies Inc ( NYSE : BHC )Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology and dermatology, a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical aesthetic devices and, through its majority ownership of Bausch + Lomb Corporation (Bausch + Lomb), branded, and branded generic pharmaceuticals, OTC products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment) in the therapeutic area of eye health. Co.'s portfolio of products falls into five operating and reportable segments: Salix, International, Solta Medical, Diversified Products and Bausch + Lomb. 29 YEAR PERFORMANCE RESULTS |
BHC Dividend History Detail BHC Dividend News BHC Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |